Francis-Xavier Barretto

Chief Scientific Officer at Swati Spentose Pvt. Ltd.

Role: Chief Scientific Officer at Swati
Location: Mumbai, MH, IN
LinkedIn followers: 500 followers

ScienceView LinkedIn profile

About Francis-Xavier Barretto

Relatively good experience in strategy development and implementation.Specializing in…

Experience

Chief Scientific Officer
Swati
Nov 2011 — Present

Education

Institute of Science, Mumbai
M.Sc.
2004 — 2006
St. Xavier's College
B.Sc.
1999 — 2004

Skills

New Business Development
Biotechnology
Pharmaceutical Industry
Pharmaceutics
Life Sciences
Market Analysis
Market Research
Strategy
Cross-Functional Team Leadership
Marketing Strategy
Regulatory Affairs
Business Strategy
Business Development

Contact information

Verified work emails, personal emails, and direct dials — unlocked in one click.

Work email
•••••@spentose.com
Personal email
•••••@•••••.com
Direct dial
+•• ••• ••• ••••

Unlock verified contacts

Free to start · No credit card required

Current company

Swati

Pharmaceutical Manufacturing · 372 employees · Founded 2005 · Mumbai, India

Swati Spentose Pvt. Ltd. is a leading specialist in Active Pharmaceutical Ingredients (APIs) and a manufacturer of complex molecules and polysaccharides. We are a part of 50+ year-old, V-Group, currently exporting to 70 countries worldwide. The company has received global FDA accreditations from several countries, including the USFDA, EDQM, and the FDA of Russia, China, Japan, Mexico, Brazil, the UK, Australia, and Canada. SSPL is currently negotiating with MIT, USA, to make a global impact in areas of biotechnology for disease areas where there are currently no medicines available. We currently operate five manufacturing sites, with expansion plans underway. Our flagship plant is located in Vapi, Gujarat. USDMFs have been filed for key products, and the company is in full compliance with GDUFA requirements. A Completeness Assessment has been successfully completed for Meloxicam (DMF #18837), and is pending for Lidocaine (DMF #25830) and Lidocaine Hydrochloride (DMF #25963). The company holds a CEP for Lidocaine Hydrochloride (R0-CEP 20•••03-Rev 00) and is in the process of obtaining CEPs for additional products. SWATI\'s journey epitomizes its inherent DNA and pedigree as a truly global, pioneering, research-oriented company. With a vision to translate scientific advancements into marketable solutions, SSPL has demonstrated resilience in navigating complex and protracted research endeavors, spanning over two decades, to deliver its products to patients in need. The company\'s mission is to persist in developing and delivering innovative health solutions for patients worldwide who are afflicted by diseases that currently lack effective treatments.

spentose.com

Find verified contacts for anyone on LinkedIn

Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.

Start for free See how it works

Free plan included · No credit card required

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

About Francis-Xavier Barretto

Experience

Chief Scientific Officer

Education

Institute of Science, Mumbai

St. Xavier's College

Skills

Find verified contacts for anyone on LinkedIn